MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Important Updates from FDA

<p>The goal for this year’s FDA Townhall at <a href="https://themedtechconference.com">The MedTech Conference</a> was to have more of an interactive session, Janet Trunzo, senior executive vice president, technology and regulatory affairs, AdvaMed, told the audience. Attendees were asked to pose their questions to the panel, which included Jeffrey Shuren, director of FDA's CDRH; Capt. Raquel Peat, PhD, director of the Office of Orthopedic Devices in CDRH, Suzanne Schwartz, MD MBA, deputy director, Office of Strategic Partnerships & Technology Innovation, CDRH; Michelle Tarver, director of Patient Science & Engagement at CDRH; and Bill Maisel, chief medical officer and director, Office of Product Evaluation and Quality at CDRH.</p><p>Read on for a few updates from FDA as panelists answered audience questions.</p>
The CDRH Townhall at The MedTech Conference provided key updates on several programs.
TAGS: Regulations
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish